Records containing: Malaria
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-03A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of L9LS in Infants in Mali and to Evaluate the Impact of L9LS on Subsequent R21/Matrix-MTM Vaccine Immunogenicity
-
CLINICAL_TRIALS study results posted · 2026-08-28A Randomized, Dose-escalation Phase I/IIa Trial With Controlled Human Malaria Infection to Evaluate Safety, Tolerability, Immunogenicity and Efficacy of an Investigational RNA-based Vaccine for Prevention of P. Falciparum Malaria in Healthy Malaria naïve Adults
-
CLINICAL_TRIALS study results posted · 2026-06-12A Phase 1, Dose Escalation, Double Blind, Placebo Controlled Clinical Trial With Controlled Human Malaria Infections (CHMI) to Evaluate Safety, Tolerability, Pharmacokinetics, and Protective Efficacy of an Anti-Malaria Human Monoclonal Antibody, MAM01, in Healthy, Malaria-Naive Adults
-
CLINICAL_TRIALS study record update · 2026-06-08Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention
-
CLINICAL_TRIALS study record update · 2026-04-27Phase 1 Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-24Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
-
CLINICAL_TRIALS study record update · 2026-04-24Phase 1 Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
-
CLINICAL_TRIALS study record update · 2026-04-24A Randomized, Double-Blind, Placebo-Controlled Phase 1 Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of Sanaria(R) PfSPZ-LARC2 Vaccine, a Late-Arresting, Replication-Competent, Genetically Attenuated Plasmodium Falciparum Vaccine by Controlled Human Malaria Infection in Malaria-Naïve Healthy Adults
-
CLINICAL_TRIALS study record update · 2026-04-24In-Vitro Testing of Pregnancy Malaria Vaccine Candidates
-
CLINICAL_TRIALS study record update · 2026-04-23A Randomized, Double-Blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 Long-Acting Injection in Healthy Adults and Adolescents in Rwanda
-
CLINICAL_TRIALS study record update · 2026-04-20Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
-
CLINICAL_TRIALS study record update · 2026-04-20Phase 1 Study of Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays
-
CLINICAL_TRIALS study record update · 2026-04-15A Randomized, Dose-escalation Phase I/IIa Trial With Controlled Human Malaria Infection to Evaluate Safety, Tolerability, Immunogenicity and Efficacy of an Investigational RNA-based Vaccine for Prevention of P. Falciparum Malaria in Healthy Malaria naïve Adults
-
CLINICAL_TRIALS study record update · 2026-04-13Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention
-
CLINICAL_TRIALS study record update · 2026-04-09A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of L9LS on R21/Matrix-M™ Vaccine Immunogenicity
-
CLINICAL_TRIALS study record update · 2026-04-08Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
-
CLINICAL_TRIALS study record update · 2026-04-08A Phase Ib Trial to Evaluate the Safety and Immunogenicity of R21/Matrix-M in a Single and Two Vial Presentation, With Different Immunisation Schedules, and When Co-Administered With EPI Vaccines in African Children
-
CLINICAL_TRIALS study record update · 2026-04-06A Randomized, Open-Label Crossover Study to Evaluate Potential Pharmacokinetic Interactions of Orally Administered Piperaquine, Pyronaridine and Artesunate in Healthy Adult Participants
-
CLINICAL_TRIALS study record update · 2026-03-30Community Dynamics of Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina Faso
-
CLINICAL_TRIALS study record update · 2026-03-19Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire
-
CLINICAL_TRIALS study record update · 2026-03-18Cross-Sectional Survey of Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, Liberia
-
CLINICAL_TRIALS study record update · 2026-03-16Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection
-
CLINICAL_TRIALS study record update · 2026-03-16Immunogenicity of a Fractional Adult Dose of the Malaria Vaccine R21/Matrix-M - A Noninferiority Trial
-
CLINICAL_TRIALS study record update · 2026-03-13Assessment of Pregnancy Outcomes Through Demographic Surveillance and Prospective Data Collection at a Health Facility in Kalifabougou, Mali
-
CLINICAL_TRIALS study record update · 2026-03-12An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria (PRIMUS)